Home Control International Signals Profit Surge on Shift to Healthcare Solutions

The latest announcement is out from Home Control International Limited ( (HK:1747) ).

Home Control International has warned investors of a sharp jump in profitability for 2025, projecting profit attributable to shareholders to rise by about 150% to 200% from 2024, based on preliminary unaudited figures. The group credited stronger business performance, led by higher sales of healthcare solutions that now account for roughly 21% of revenue versus 14% a year earlier, and the absence of a prior-year one-off impairment, signalling a more profitable product mix and cleaner earnings base ahead of its full-year results due by end-March 2026.

The improvement in margins from the growing healthcare segment, which carries higher gross profit than traditional control solutions, points to a strategic tilt toward more lucrative offerings. While the figures remain subject to audit and potential adjustment, the positive profit alert underscores a notable earnings rebound for shareholders and may bolster the company’s standing in its markets, though management has urged investors to exercise caution until audited results are released.

The most recent analyst rating on (HK:1747) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.

More about Home Control International Limited

Home Control International Limited is a Hong Kong-listed company that develops and sells control and healthcare solutions. Its business mix is shifting toward higher-margin healthcare products, which have become an increasingly important contributor to group revenue and profitability as their share of total sales expands.

Average Trading Volume: 469,355

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.36B

See more insights into 1747 stock on TipRanks’ Stock Analysis page.